商业 来源:北京商报 时间:2023-05-26 20:57:00
【资料图】
北京商报讯(记者 姚倩 李想)5月26日,华润双鹤晚间公告,近日全资子公司华润双鹤利民药业(济南)有限公司收到了国家药品监督管理局颁发的左乙拉西坦注射用浓溶液药品注册证书,批准该药品生产。左乙拉西坦注射用浓溶液适用于成人及4岁以上儿童癫痫患者部分性发作(伴或不伴继发性全面性发作)的治疗。
标签:
上一篇:2023年国内磷矿石行业供需分析 磷矿石市场结构分析
下一篇:最后一页
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
22-09-30
22-04-11
22-04-11
22-04-11
22-04-11
22-04-11
22-04-11
22-04-11
22-04-11
22-04-11
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26
23-05-26